University Library
  • Login
A gateway to Melbourne's research publications
Minerva Access is the University's Institutional Repository. It aims to collect, preserve, and showcase the intellectual output of staff and students of the University of Melbourne for a global audience.
View Item 
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Doherty Institute
  • Doherty Institute - Research Publications
  • View Item
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Doherty Institute
  • Doherty Institute - Research Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

    Eliminating the latent HIV reservoir by reactivation strategies Advancing to clinical trials

    Thumbnail
    Download
    Published version (411.6Kb)

    Citations
    Scopus
    Web of Science
    Altmetric
    42
    31
    Author
    Rasmussen, TA; Tolstrup, M; Winckelmann, A; Ostergaard, L; Sogaard, OS
    Date
    2013-04-01
    Source Title
    Human Vaccines and Immunotherapeutics
    Publisher
    TAYLOR & FRANCIS INC
    University of Melbourne Author/s
    Rasmussen, Thomas
    Affiliation
    Doherty Institute
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Rasmussen, T. A., Tolstrup, M., Winckelmann, A., Ostergaard, L. & Sogaard, O. S. (2013). Eliminating the latent HIV reservoir by reactivation strategies Advancing to clinical trials. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 9 (4), pp.790-799. https://doi.org/10.4161/hv.23202.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/255678
    DOI
    10.4161/hv.23202
    Abstract
    Combination antiretroviral therapy (cART) has transformed HIV from a deadly to a chronic disease, but HIV patients are still burdened with excess morbidity and mortality, long-term toxicities from cART, stigmatization, and insufficient access to cART worldwide. Thus, a cure for HIV would have enormous impact on society as well as the individual. As the complexity and mechanisms of HIV persistence during therapy are being unraveled, new therapeutic targets for HIV eradication are discovered. Substances that activate HIV production in the latently infected cells have recently received much attention. By turning on expression of latent HIV proviruses, reactivation strategies could contribute to the eradication HIV infection. Compounds that are currently being or soon to be tested in clinical trials are emphasized. The results from these trials will provide important clues as to whether or not reactivating strategies could become significant components of a cure for HIV.

    Export Reference in RIS Format     

    Endnote

    • Click on "Export Reference in RIS Format" and choose "open with... Endnote".

    Refworks

    • Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References


    Collections
    • Minerva Elements Records [45689]
    • Doherty Institute - Research Publications [371]
    Minerva AccessDepositing Your Work (for University of Melbourne Staff and Students)NewsFAQs

    BrowseCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    My AccountLoginRegister
    StatisticsMost Popular ItemsStatistics by CountryMost Popular Authors